These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28619026)

  • 101. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.
    Taylor EN; Hoofnagle AN; Curhan GC
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):667-75. PubMed ID: 25623233
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Haemoglobin A1c variability as an independent correlate of atherosclerosis and cardiovascular disease in Chinese type 2 diabetes.
    Mo Y; Zhou J; Ma X; Zhu W; Zhang L; Li J; Lu J; Hu C; Bao Y; Jia W
    Diab Vasc Dis Res; 2018 Sep; 15(5):402-408. PubMed ID: 29848065
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.
    Eckberg K; Kramer H; Wolf M; Durazo-Arvizu R; Tayo B; Luke A; Cooper R
    Nephrol Dial Transplant; 2015 Apr; 30(4):630-5. PubMed ID: 25358495
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
    McGrath ER; Himali JJ; Levy D; Conner SC; Pase MP; Abraham CR; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    PLoS One; 2019; 14(3):e0213321. PubMed ID: 30830941
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.
    Kosk D; Kramer H; Luke A; Camacho P; Bovet P; Rhule JP; Forrester T; Wolf M; Sempos C; Melamed ML; Dugas LR; Cooper R; Durazo-Arvizu R
    J Bone Miner Metab; 2017 Nov; 35(6):666-674. PubMed ID: 27942978
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies.
    van der Vaart A; Eelderink C; van Beek AP; Bakker SJL; van Dijk PR; de Borst MH
    J Clin Endocrinol Metab; 2023 Sep; 108(10):e971-e978. PubMed ID: 37139691
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies.
    Qin Z; Liu X; Song M; Zhou Q; Yu J; Zhou B; Wu Y; He Y; Huang L
    Atherosclerosis; 2017 Jun; 261():1-11. PubMed ID: 28411494
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Association of Serum Fibroblast Growth Factor 23 and FGF23 Gene Variants with Chronic Kidney Disease in Patients with Type 2 Diabetes and Essential Hypertension.
    Mendoza-Carrera F; Farías-Basulto A; Gómez-García EF; Cortés-Sanabria L; Cueto-Manzano AM; Rizo-de la Torre LDC; Leal-Cortés CA
    Arch Med Res; 2023 Apr; 54(3):239-246. PubMed ID: 36907780
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Effect of pioglitazone on serum FGF23 levels among patients with diabetic kidney disease: a randomized controlled trial.
    Triwatana W; Satirapoj B; Supasyndh O; Nata N
    Int Urol Nephrol; 2023 May; 55(5):1255-1262. PubMed ID: 36441433
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes.
    Liu Z; Peng Y; Li S; Lin Y; Huang Y; Chen W; Bao C; Zhou Z; Lin Z; Chen L
    BMC Endocr Disord; 2023 Dec; 23(1):272. PubMed ID: 38057786
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The role of Klotho and FGF23 in cardiovascular outcomes of diabetic patients with chronic limb threatening ischemia: a prospective study.
    Biscetti F; Rando MM; Cecchini AL; Nicolazzi MA; Rossini E; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Gasbarrini A; Massetti M; Flex A
    Sci Rep; 2023 Apr; 13(1):6150. PubMed ID: 37061530
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence.
    Miyamura M; Fujita S; Morita H; Sakane K; Okamoto Y; Sohmiya K; Hoshiga M; Ishizaka N
    Circ J; 2015; 79(8):1742-8. PubMed ID: 26016926
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Fibroblast growth factor 23 is associated with the development of gestational diabetes mellitus.
    Hocher CF; Chen X; Zuo J; Horvathova K; Hocher B; Krämer BK; Chu C
    Diabetes Metab Res Rev; 2023 Nov; 39(8):e3704. PubMed ID: 37553983
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians.
    Bobbert T; Schwarz F; Fischer-Rosinsky A; Pfeiffer AF; Möhlig M; Mai K; Spranger J
    Diabetes Care; 2013 Jan; 36(1):145-9. PubMed ID: 22933429
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort.
    Zhang R; Li Y; Zhou X; Zhang F; Li M; Zhang S; Zhang X; Wen X; Ji L
    Medicine (Baltimore); 2021 Dec; 100(50):e28238. PubMed ID: 34918690
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Increased Serum WISP1 Levels are Associated with Lower Extremity Atherosclerotic Disease in Patients with Type 2 Diabetes Mellitus.
    Cheng Y; Du X; Zhang B; Zhang J
    Exp Clin Endocrinol Diabetes; 2022 Apr; 130(4):248-253. PubMed ID: 33930896
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.
    Souma N; Isakova T; Lipiszko D; Sacco RL; Elkind MS; DeRosa JT; Silverberg SJ; Mendez AJ; Dong C; Wright CB; Wolf M
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3779-3786. PubMed ID: 27501282
    [TBL] [Abstract][Full Text] [Related]  

  • 118. High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects.
    Chen C; Cheung BM; Tso AW; Wang Y; Law LS; Ong KL; Wat NM; Xu A; Lam KS
    Diabetes Care; 2011 Sep; 34(9):2113-5. PubMed ID: 21750278
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Cerebrospinal fluid FGF23 levels correlate with a measure of impulsivity.
    Li H; Cao Z; Xu J; Wang F; Xiong R; Xu Z; Luo X; Li G; Tan X; Liu Z; Gao Z; Kang Y; Xiao J; Liu Y; Li X
    Psychiatry Res; 2018 Jun; 264():394-397. PubMed ID: 29677623
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Serum Levels of Brain-Derived Neurotrophic Factor Are Associated with Diabetes Risk, Complications, and Obesity: a Cohort Study from Chinese Patients with Type 2 Diabetes.
    Li B; Lang N; Cheng ZF
    Mol Neurobiol; 2016 Oct; 53(8):5492-9. PubMed ID: 26454822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.